Literature DB >> 19443700

Dominant role of the sst1 locus in pathogenesis of necrotizing lung granulomas during chronic tuberculosis infection and reactivation in genetically resistant hosts.

Alexander V Pichugin1, Bo-Shiun Yan, Alex Sloutsky, Lester Kobzik, Igor Kramnik.   

Abstract

Significant host heterogeneity in susceptibility to tuberculosis exists both between and within mammalian species. Using a mouse model of infection with virulent Mycobacterium tuberculosis (Mtb), we identified the genetic locus sst1 that controls the progression of pulmonary tuberculosis in immunocompetent hosts. In this study, we demonstrate that within the complex, multigenic architecture of tuberculosis susceptibility, sst1 functions to control necrosis within tuberculosis lesions in the lungs; this lung-specific sst1 effect is independent of both the route of infection and genetic background of the host. Moreover, sst1-dependent necrosis was observed at low bacterial loads in the lungs during reactivation of the disease after termination of anti-tuberculosis drug therapy. We demonstrate that in sst1-susceptible hosts, nonlinked host resistance loci control both lung inflammation and production of inflammatory mediators by Mtb-infected macrophages. Although interactions of the sst1-susceptible allele with genetic modifiers determine the type of the pulmonary disease progression, other resistance loci do not abolish lung necrosis, which is, therefore, the core sst1-dependent phenotype. Sst1-susceptible mice from tuberculosis-resistant and -susceptible genetic backgrounds reproduce a clinical spectrum of pulmonary tuberculosis and may be used to more accurately predict the efficacy of anti-tuberculosis interventions in genetically heterogeneous human populations.

Entities:  

Mesh:

Year:  2009        PMID: 19443700      PMCID: PMC2684184          DOI: 10.2353/ajpath.2009.081075

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

Review 1.  Immunity to intracellular pathogens as a complex genetic trait.

Authors:  Igor Kramnik; Victor Boyartchuk
Journal:  Curr Opin Microbiol       Date:  2002-02       Impact factor: 7.934

2.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta.

Authors:  C Manca; L Tsenova; A Bergtold; S Freeman; M Tovey; J M Musser; C E Barry; V H Freedman; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

3.  Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis.

Authors:  A A Chackerian; T V Perera; S M Behar
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis.

Authors:  I Kramnik; W F Dietrich; P Demant; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

5.  Multigenic control of tuberculosis resistance: analysis of a QTL on mouse chromosome 7 and its synergism with sst1.

Authors:  J Sissons; B-S Yan; A V Pichugin; A Kirby; M J Daly; I Kramnik
Journal:  Genes Immun       Date:  2008-09-11       Impact factor: 2.676

6.  Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity.

Authors:  Alissa A Chackerian; Jennifer M Alt; Thushara V Perera; Christopher C Dascher; Samuel M Behar
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 7.  Genetic dissection of host resistance to Mycobacterium tuberculosis: the sst1 locus and the Ipr1 gene.

Authors:  I Kramnik
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

8.  Dual-promoter lentiviral system allows inducible expression of noxious proteins in macrophages.

Authors:  Hui Pan; Gustavo Mostoslavsky; Evgeny Eruslanov; Darrell N Kotton; Igor Kramnik
Journal:  J Immunol Methods       Date:  2007-10-18       Impact factor: 2.303

9.  Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible nitric oxide synthase, are critical for granuloma necrosis in a mouse model of mycobacteria-induced pulmonary immunopathology.

Authors:  S Ehlers; J Benini; H D Held; C Roeck; G Alber; S Uhlig
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

10.  Progression of pulmonary tuberculosis and efficiency of bacillus Calmette-Guérin vaccination are genetically controlled via a common sst1-mediated mechanism of innate immunity.

Authors:  Bo-Shiun Yan; Alexander V Pichugin; Ousman Jobe; Laura Helming; Evgeniy B Eruslanov; José A Gutiérrez-Pabello; Mauricio Rojas; Yuriy V Shebzukhov; Lester Kobzik; Igor Kramnik
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

View more
  53 in total

1.  Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.

Authors:  Marcela Henao-Tamayo; Andrés Obregón-Henao; Elizabeth Creissen; Crystal Shanley; Ian Orme; Diane J Ordway
Journal:  Clin Vaccine Immunol       Date:  2014-11-12

2.  MMPs in tuberculosis: granuloma creators and tissue destroyers.

Authors:  Padmini Salgame
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

Review 3.  Development of new vaccines and drugs for TB: limitations and potential strategic errors.

Authors:  Ian M Orme
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

4.  Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.

Authors:  Emily R Driver; Gavin J Ryan; Donald R Hoff; Scott M Irwin; Randall J Basaraba; Igor Kramnik; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

Review 5.  Mouse model of tuberculosis.

Authors:  Andrea M Cooper
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-25       Impact factor: 6.915

6.  Mycobacterium tuberculosis pellicles express unique proteins recognized by the host humoral response.

Authors:  Patrick W Kerns; David F Ackhart; Randall J Basaraba; Jeff G Leid; Mark E Shirtliff
Journal:  Pathog Dis       Date:  2014-02-26       Impact factor: 3.166

7.  Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas.

Authors:  Scott M Irwin; Veronica Gruppo; Elizabeth Brooks; Janet Gilliland; Michael Scherman; Matthew J Reichlen; Rachel Leistikow; Igor Kramnik; Eric L Nuermberger; Martin I Voskuil; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

8.  S100A8/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis.

Authors:  Radha Gopal; Leticia Monin; Diana Torres; Samantha Slight; Smriti Mehra; Kyle C McKenna; Beth A Fallert Junecko; Todd A Reinhart; Jay Kolls; Renata Báez-Saldaña; Alfredo Cruz-Lagunas; Tatiana S Rodríguez-Reyna; Nathella Pavan Kumar; Phillipe Tessier; Johannes Roth; Moisés Selman; Enrique Becerril-Villanueva; Javier Baquera-Heredia; Bridgette Cumming; Victoria O Kasprowicz; Adrie J C Steyn; Subash Babu; Deepak Kaushal; Joaquín Zúñiga; Thomas Vogl; Javier Rangel-Moreno; Shabaana A Khader
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

9.  Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate.

Authors:  Susan L Baldwin; Valerie A Reese; Po-Wei D Huang; Elyse A Beebe; Brendan K Podell; Steven G Reed; Rhea N Coler
Journal:  Clin Vaccine Immunol       Date:  2015-12-09

Review 10.  Permutations of time and place in tuberculosis.

Authors:  Paul T Elkington; Jon S Friedland
Journal:  Lancet Infect Dis       Date:  2015-08-28       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.